INCY · NASDAQ
Incyte (INCY) Stock Price & Fundamentals
Incyte (INCY) closed at $994.72 on Oct 9, 2026, up 1.12% from the previous close of $983.68.
Share price, past year
1Y +28.94%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $994.72 |
| Sep 30, 2026 | $984.19 |
| Aug 31, 2026 | $996.08 |
| Jul 31, 2026 | $1,010.80 |
| Jun 30, 2026 | $1,012.08 |
| May 29, 2026 | $1,061.83 |
| Apr 30, 2026 | $1,085.51 |
| Mar 31, 2026 | $1,089.53 |
| Feb 27, 2026 | $1,015.70 |
| Jan 30, 2026 | $914.12 |
| Dec 31, 2025 | $847.58 |
| Nov 28, 2025 | $786.13 |
| Oct 31, 2025 | $787.53 |
Key statistics
- Market cap
- $198.89B
- P/E (TTM)
- 140.5
- EPS (TTM)
- $7.08
- Revenue (TTM)
- $5.36B
- Net income (TTM)
- $1.43B
- Shares outstanding
- 199.9M
- Dividend yield
- —
- 52-week range
- $767.12 – $1,117.42
Incyte's market cap is $198.89B, based on a share price of $994.72 and 199.9M shares outstanding as of Mar 31, 2026.
Financials
Incyte reported revenue of $5.14B for fiscal 2025, up 21.22% from fiscal 2024.
Incyte earned net income of $1.29B in fiscal 2025, a net margin of 25.0%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $5.14B | +21.2% | $1.29B | 25.0% | $6.41 | — |
| FY2024ended Dec 31, 2024 | $4.24B | +14.8% | $32.62M | 0.8% | $0.15 | — |
| FY2023ended Dec 31, 2023 | $3.70B | +8.9% | $597.60M | 16.2% | $2.65 | — |
| FY2022ended Dec 31, 2022 | $3.39B | +13.7% | $340.66M | 10.0% | $1.52 | — |
| FY2021ended Dec 31, 2021 | $2.99B | +12.0% | $948.58M | 31.8% | $4.27 | — |
| FY2020ended Dec 31, 2020 | $2.67B | +23.5% | −$295.70M | −11.1% | −$1.36 | — |
| FY2019ended Dec 31, 2019 | $2.16B | +14.7% | $446.91M | 20.7% | $2.05 | — |
| FY2018ended Dec 31, 2018 | $1.88B | +22.5% | $109.49M | 5.8% | $0.51 | — |
| FY2017ended Dec 31, 2017 | $1.54B | +38.9% | −$313.14M | −20.4% | −$1.53 | — |
| FY2016ended Dec 31, 2016 | $1.11B | — | $104.22M | 9.4% | $0.54 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $1.27B | $303.33M | $1.47 |
| Q4 FY2025ended Dec 31, 2025 | $1.51B | $299.28M | $1.46 |
| Q3 FY2025ended Sep 30, 2025 | $1.37B | $424.17M | $2.11 |
| Q2 FY2025ended Jun 30, 2025 | $1.22B | $405.00M | $2.04 |
| Q1 FY2025ended Mar 31, 2025 | $1.05B | $158.20M | $0.80 |
| Q4 FY2024ended Dec 31, 2024 | $1.18B | $201.21M | $0.90 |
| Q3 FY2024ended Sep 30, 2024 | $1.14B | $106.46M | $0.54 |
| Q2 FY2024ended Jun 30, 2024 | $1.04B | −$444.60M | −$2.04 |
Company profile
- Name
- Incyte Corporation
- Ticker
- INCY
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Commercial Physical & Biological Research
- Headquarters
- 1801 Augustine Cut-Off, Wilmington, DE 19803
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000879169
Recent SEC filings
- Aug 31, 2026
- Jul 28, 2026
- Jul 28, 2026
- Jul 6, 2026
- Jun 22, 2026
- Jun 9, 2026
- Jun 8, 2026
- Apr 28, 2026
Frequently asked questions
What is Incyte's stock price?
Incyte (INCY) closed at $994.72 on Oct 9, 2026, up 1.12% from the previous close of $983.68.
What is Incyte's market cap?
Incyte's market cap is $198.89B, based on a share price of $994.72 and 199.9M shares outstanding as of Mar 31, 2026.
How much revenue does Incyte make?
Incyte reported revenue of $5.14B for fiscal 2025, up 21.22% from fiscal 2024.
What is INCY's P/E ratio?
Incyte's price-to-earnings ratio is 140.5, based on trailing twelve-month diluted EPS of $7.08.
Does Incyte pay a dividend?
Incyte's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Incyte Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures